- Report
- July 2024
- 100 Pages
Global
From €3413EUR$3,750USD£2,899GBP
- Report
- May 2024
- 160 Pages
Global
From €3595EUR$3,950USD£3,054GBP
- Newsletter
- April 2025
Global
€2726EUR$2,995USD£2,315GBP
- Report
- January 2025
- 51 Pages
Global
From €4546EUR$4,995USD£3,861GBP
- Report
- March 2024
- 664 Pages
Global
From €4505EUR$4,950USD£3,827GBP
- Report
- June 2023
- 88 Pages
Global
From €4232EUR$4,650USD£3,595GBP
- Report
- September 2024
- 150 Pages
China
From €5416EUR$5,950USD£4,600GBP
- Report
- April 2024
- 150 Pages
Global
From €5416EUR$5,950USD£4,600GBP
- Report
- November 2023
- 170 Pages
Global
From €5416EUR$5,950USD£4,600GBP
- Report
- January 2023
- 135 Pages
Global
From €2266EUR$2,490USD£1,925GBP
- Report
- November 2021
- 86 Pages
Global
From €4505EUR$4,950USD£3,827GBP
- Report
- November 2021
- 122 Pages
Global
From €4505EUR$4,950USD£3,827GBP
- Report
- March 2024
- 178 Pages
Global
From €2275EUR$2,500USD£1,933GBP
- Report
- October 2023
- 190 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- July 2023
- 87 Pages
Europe
From €3641EUR$4,000USD£3,092GBP
- Report
- July 2022
- 112 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- April 2022
- 111 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- February 2024
- 115 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- April 2023
- 115 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- April 2023
- 135 Pages
Global
From €4323EUR$4,750USD£3,672GBP

Orthobiologics is a field of biotechnology that focuses on the development of products and treatments to improve musculoskeletal health. It includes the use of biological materials such as stem cells, growth factors, and proteins to repair, regenerate, and replace damaged or diseased tissues. Orthobiologics is used to treat a variety of musculoskeletal conditions, including fractures, tendon and ligament injuries, and degenerative joint diseases. It is also used to improve the healing of bone and soft tissue after surgery.
Orthobiologics is a rapidly growing field, with new products and treatments being developed to improve patient outcomes. It is becoming increasingly important in the treatment of musculoskeletal conditions, as it offers a more natural and less invasive approach than traditional treatments.
Some companies in the Orthobiologics market include Acelity, AlloSource, Arthrex, Bioventus, DePuy Synthes, Exactech, Integra LifeSciences, Medtronic, MiMedx, Orthofix, and Stryker. Show Less Read more